|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US6334997B1
(en)
*
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
EP0979306A4
(en)
*
|
1997-02-14 |
2004-09-01 |
Univ George Washington |
Procedure for measuring DNA synthesis rates
|
|
US6312450B1
(en)
|
1997-05-20 |
2001-11-06 |
Natural Vision Center, Inc. |
System and method for improving the appearance of skin
|
|
US6884429B2
(en)
*
|
1997-09-05 |
2005-04-26 |
Isotechnika International Inc. |
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
|
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
|
EP1645565B1
(en)
*
|
1997-10-08 |
2009-02-18 |
Isotechnika Inc. |
Deuterated cyclosporine analogs and their use as immunomodulating agents
|
|
AU750245B2
(en)
|
1997-10-08 |
2002-07-11 |
Aurinia Phamaceuticals Inc. |
Deuterated cyclosporine analogs and their use as immunomodulating agents
|
|
US6333342B1
(en)
*
|
1998-11-04 |
2001-12-25 |
Isotechnika, Inc |
Methods of pharmacological treatment using S(−) amlodipine
|
|
US6376531B1
(en)
|
1998-11-13 |
2002-04-23 |
Rupert Charles Bell |
Method of treatment using deuterium compounds
|
|
US7323341B1
(en)
*
|
1999-07-09 |
2008-01-29 |
Jasper John P |
Stable isotopic identification and method for identifying products by isotopic concentration
|
|
US6254594B1
(en)
|
1999-07-30 |
2001-07-03 |
Quadrivium, Llc |
Disposable light source for photothermal treatment of human tissue
|
|
RU2181297C2
(ru)
*
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
|
US6579630B2
(en)
|
2000-12-07 |
2003-06-17 |
Canon Kabushiki Kaisha |
Deuterated semiconducting organic compounds used for opto-electronic devices
|
|
US6872408B2
(en)
*
|
2001-09-07 |
2005-03-29 |
Rupert C. Bell |
Method of treating bipolar disorders using deuterium-substituted carbonate
|
|
EP1435944B1
(en)
|
2001-10-16 |
2009-09-30 |
Memory Pharmaceutical Corporation |
4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
|
|
SI1436321T1
(sl)
|
2001-10-19 |
2006-12-31 |
Isotechnika Inc |
Sinteza analogov ciklosporina
|
|
RU2201255C1
(ru)
*
|
2001-12-26 |
2003-03-27 |
Эпштейн Олег Ильич |
Лекарственное средство и способ регуляции сосудистого тонуса
|
|
DE10205432A1
(de)
*
|
2002-02-07 |
2003-08-21 |
Bdd Group Holding Ag Zug |
Deuterierte biphenylsubstituierte Spirocyclopentanimidazoline sowie diese Verbindungen enthaltende Arzneimittel
|
|
UA76640C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
|
|
UA76639C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
|
|
EP2305664A1
(en)
|
2002-08-30 |
2011-04-06 |
Memory Pharmaceuticals Corporation |
Anabaseine derivatives useful in the treatment of neurodegeneratives diseases
|
|
CA2499128C
(en)
|
2002-09-25 |
2012-07-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
|
BR0315705A
(pt)
|
2002-11-19 |
2005-09-06 |
Memory Pharm Corp |
Inibidores de fosfodiesterase-4
|
|
JP2006524232A
(ja)
*
|
2003-03-17 |
2006-10-26 |
アルバニー モレキュラー リサーチ インコーポレーティッド |
新規サイクロスポリン
|
|
AU2004232958A1
(en)
*
|
2003-04-16 |
2004-11-04 |
F.-Hoffmann La-Roche Inc. |
4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
|
AU2004232973A1
(en)
*
|
2003-04-18 |
2004-11-04 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
|
WO2005020840A2
(en)
*
|
2003-08-21 |
2005-03-10 |
Thomas Tobin |
Composition and method for marking procaine penicillin
|
|
RU2253478C1
(ru)
*
|
2003-10-01 |
2005-06-10 |
Эпштейн Олег Ильич |
Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
|
|
JP2007512338A
(ja)
|
2003-11-21 |
2007-05-17 |
メモリー・ファーマシューティカルズ・コーポレイション |
Ｌ型カルシウムチャンネルブロッカーとコリンエステラーゼ阻害剤を用いた組成物及び処置方法
|
|
BRPI0508771A
(pt)
|
2004-03-25 |
2007-08-14 |
Memory Pharm Corp |
indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
|
|
US7705036B2
(en)
*
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
|
EP1729814A2
(en)
*
|
2004-04-01 |
2006-12-13 |
Cardiome Pharma Corp. |
Pegylated ion channel modulating compounds
|
|
EP1804823A4
(en)
*
|
2004-09-29 |
2010-06-09 |
Amr Technology Inc |
NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
|
|
US7378391B2
(en)
*
|
2004-09-29 |
2008-05-27 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
|
US7361636B2
(en)
*
|
2004-10-06 |
2008-04-22 |
Amr Technology, Inc. |
Cyclosporin alkynes and their utility as pharmaceutical agents
|
|
CN101166733A
(zh)
|
2004-10-15 |
2008-04-23 |
记忆药物公司 |
作为磷酸二酯酶4抑制剂的吡唑衍生物
|
|
AU2005295350A1
(en)
*
|
2004-10-20 |
2006-04-27 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
|
CA2586925C
(en)
|
2004-11-18 |
2016-06-07 |
Cardiome Pharma Corp. |
Synthetic process for aminocyclohexyl ether compounds
|
|
CA2612375C
(en)
|
2005-06-15 |
2013-08-06 |
Cardiome Pharma Corp. |
Synthetic processes for the preparation of aminocyclohexyl ether compounds
|
|
EP1912947A1
(en)
*
|
2005-07-26 |
2008-04-23 |
Nycomed GmbH |
Isotopically substituted pantoprazole
|
|
NZ565078A
(en)
*
|
2005-07-26 |
2010-03-26 |
Nycomed Gmbh |
Deuterated proton pump inhibitors such as omeprazole
|
|
US7863274B2
(en)
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
|
EA014432B1
(ru)
*
|
2005-07-29 |
2010-12-30 |
Консерт Фармасьютикалс Инк. |
Дейтерированные производные 1,3-бензодиоксола
|
|
JP2009511481A
(ja)
*
|
2005-10-06 |
2009-03-19 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
増強された治療特性を持つ、胃Ｈ＋，Ｋ＋−ＡＴＰａｓｅの重水素化阻害剤
|
|
WO2007064697A1
(en)
|
2005-12-01 |
2007-06-07 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
|
|
RU2309732C1
(ru)
*
|
2006-03-13 |
2007-11-10 |
Олег Ильич Эпштейн |
Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
|
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
|
US7696165B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
|
AU2007267612A1
(en)
*
|
2006-05-26 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted carboxylic acid compounds
|
|
US8367414B2
(en)
|
2006-05-30 |
2013-02-05 |
Jasper John P |
Tracing processes between precursors and products by utilizing isotopic relationships
|
|
WO2007143507A2
(en)
*
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
CN101516879A
(zh)
|
2006-06-05 |
2009-08-26 |
奥斯拜客斯制药有限公司 |
具有催眠作用的取代的咪唑并吡啶化合物的制备及用途
|
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
|
WO2008021891A2
(en)
*
|
2006-08-08 |
2008-02-21 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
|
|
US7872013B2
(en)
|
2006-08-16 |
2011-01-18 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of opioid analgesics
|
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
|
CA2669687C
(en)
*
|
2006-11-15 |
2013-09-10 |
Forest Laboratories Holdings Limited |
Phthalazine derivatives
|
|
WO2008063600A2
(en)
*
|
2006-11-17 |
2008-05-29 |
Concert Pharmaceuticals Inc. |
Triazolyl tropane derivatives
|
|
WO2008070619A1
(en)
*
|
2006-12-04 |
2008-06-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated oxazolidinones and their use as antibiotics
|
|
WO2008076949A2
(en)
|
2006-12-15 |
2008-06-26 |
Concert Pharmaceuticals Inc. |
Quinazoline derivatives and methods of treatment
|
|
US8080549B2
(en)
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
WO2008088727A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
EP2125717B1
(en)
|
2007-02-26 |
2013-07-03 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of silodosin as alpha ia-adrenoreceptor antagonists
|
|
ATE509015T1
(de)
|
2007-03-07 |
2011-05-15 |
Concert Pharmaceuticals Inc |
Deuterierte piperazinderivate als verbindungen gegen angina
|
|
PL2125698T3
(pl)
|
2007-03-15 |
2017-03-31 |
Auspex Pharmaceuticals, Inc. |
Deuterowana wenlafaksyna-d9
|
|
WO2008115442A1
(en)
|
2007-03-16 |
2008-09-25 |
Concert Pharmceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
|
WO2008124803A1
(en)
|
2007-04-10 |
2008-10-16 |
Auspex Pharmaceuticals, Inc. |
Substituted deuterium enriched thiophenes for the treatment of hypertension
|
|
ES2401914T3
(es)
|
2007-04-25 |
2013-04-25 |
Concert Pharmaceuticals Inc. |
Análogos de Cilostazol
|
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
|
JP2010525081A
(ja)
|
2007-04-26 |
2010-07-22 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
重水素標識ケタミン
|
|
CA3208128A1
(en)
|
2007-05-01 |
2008-11-13 |
Sun Pharmaceutical Industries, Inc. |
Morphinan compounds
|
|
JP4944244B2
(ja)
|
2007-05-01 |
2012-05-30 |
コンサート ファーマシューティカルズ インコーポレイテッド |
モルフィナン化合物
|
|
US7820666B2
(en)
|
2007-05-08 |
2010-10-26 |
Concert Pharmaceuticals, Inc. |
Tetrahydrotriazolopyrazine derivatives and uses thereof
|
|
US20080280970A1
(en)
|
2007-05-08 |
2008-11-13 |
Czarnik Anthony W |
Deuterium-enriched atorvastatin
|
|
HUP0700353A2
(en)
*
|
2007-05-18 |
2008-12-29 |
Richter Gedeon Nyrt |
Metabolites of (thio)carbamoyl-cyclohexane derivatives
|
|
US7531685B2
(en)
*
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
|
WO2008151179A2
(en)
|
2007-06-04 |
2008-12-11 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
JP2010529196A
(ja)
|
2007-06-12 |
2010-08-26 |
コンサート ファーマシューティカルズ インコーポレイテッド |
アザペプチド誘導体
|
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
|
US20080318964A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched eszopiclone
|
|
US7915309B2
(en)
|
2007-06-20 |
2011-03-29 |
Protia, Llc |
Deuterium-enriched oseltamivir
|
|
JP5587184B2
(ja)
|
2007-06-20 |
2014-09-10 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
繊維症阻害剤としての置換ｎ−アリールピリジノン
|
|
WO2009009531A2
(en)
|
2007-07-09 |
2009-01-15 |
Concert Pharmaceuticals Inc. |
Pyrimidinecarboxamide derivatives for the treatment of hiv infections
|
|
JP2010535234A
(ja)
*
|
2007-07-30 |
2010-11-18 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換インドール
|
|
JP5389028B2
(ja)
|
2007-08-14 |
2014-01-15 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換オキサゾリジノン誘導体
|
|
US20090062182A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched dalbavancin
|
|
US7767860B2
(en)
|
2007-09-06 |
2010-08-03 |
Auspex Pharmaceuticals, Inc |
Substituted amino alcohols
|
|
US20090069395A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched famotidine
|
|
US8669268B2
(en)
|
2007-09-12 |
2014-03-11 |
Deuterx, Llc |
Deuterium-enriched prasugrel
|
|
US8304435B2
(en)
|
2007-09-12 |
2012-11-06 |
Deuteria Pharmaceuticals Inc. |
Deuterium-enriched donepezil
|
|
US8288414B2
(en)
|
2007-09-12 |
2012-10-16 |
Deuteria Pharmaceuticals, Inc. |
Deuterium-enriched lenalidomide
|
|
MX2010002679A
(es)
|
2007-09-12 |
2010-03-29 |
Concert Pharmaceuticals Inc |
Derivados de 4-oxoquinolina deuterados para el tratamiento de la infeccion por el virus de inmunodeficiencia humana.
|
|
JP5647519B2
(ja)
|
2007-09-13 |
2014-12-24 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化カテコールおよびベンゾ［ｄ］［１，３］ジオキソールおよびその誘導体の合成
|
|
US20090076161A1
(en)
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bupropion
|
|
US7919516B2
(en)
|
2007-09-13 |
2011-04-05 |
Protia, Llc |
Deuterium-enriched ondansetron
|
|
US8026249B2
(en)
|
2007-09-14 |
2011-09-27 |
Deutena Pharmaceuticals, Inc. |
Deuterium-enriched topotecan
|
|
US7776866B2
(en)
|
2007-09-15 |
2010-08-17 |
Protia, Llc |
Deuterium-enriched risperidone
|
|
US7842675B2
(en)
|
2007-09-15 |
2010-11-30 |
Protia, Llc |
Deuterium-enriched capecitabine
|
|
US7956080B2
(en)
|
2007-09-25 |
2011-06-07 |
Protra, LLC |
Deuterium-enriched SDX-101
|
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
|
US20090082259A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched octreotide
|
|
US20090105338A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
|
WO2009051782A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
|
US8592487B2
(en)
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
|
WO2009067225A2
(en)
*
|
2007-11-20 |
2009-05-28 |
Concert Pharmaceuticals, Inc. |
Boceprevir derivatives for the treatment of hcv infections
|
|
US7875610B2
(en)
*
|
2007-12-03 |
2011-01-25 |
Richter Gedeon Nyrt. |
Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
|
|
US8338425B2
(en)
|
2007-12-10 |
2012-12-25 |
Concert Pharmaceuticals, Inc. |
Heterocyclic kinase inhibitors
|
|
WO2009079637A1
(en)
*
|
2007-12-18 |
2009-06-25 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
|
WO2009094216A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
|
US8609673B2
(en)
|
2008-01-22 |
2013-12-17 |
Concert Pharmaceuticals, Inc. |
Vandetanib derivatives
|
|
CA2714414A1
(en)
|
2008-02-13 |
2009-08-20 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
CA2715760C
(en)
*
|
2008-02-21 |
2017-06-13 |
Mitsubishi Tanabe Pharma Corporation |
Solid preparation for oral administration of cariprazine hydrochloride
|
|
WO2009108375A1
(en)
|
2008-02-29 |
2009-09-03 |
Concert Pharmaceuticals, Inc |
Substituted xanthine derivatives
|
|
CA2715036A1
(en)
*
|
2008-03-14 |
2009-09-17 |
Retrotope, Inc. |
Therapies for cancer using isotopically substituted lysine
|
|
KR20100134680A
(ko)
*
|
2008-03-20 |
2010-12-23 |
포레스트 래보러토리즈 홀딩스 리미티드 |
스테아로일-ｃｏａ 불포화효소의 저해물질로서 신규한 피페리딘 유도체
|
|
EP2307023A4
(en)
*
|
2008-03-20 |
2011-07-20 |
Forest Lab Holdings Ltd |
NEW PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL COA DESATURASE
|
|
US8367674B2
(en)
|
2008-04-17 |
2013-02-05 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
WO2009148600A2
(en)
*
|
2008-06-06 |
2009-12-10 |
Concert Pharmaceuticals, Inc. |
Deuterated lysine-based compounds
|
|
WO2009154754A2
(en)
|
2008-06-17 |
2009-12-23 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
|
US20100016297A1
(en)
*
|
2008-06-24 |
2010-01-21 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
|
WO2009158005A1
(en)
*
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Benzazepinone compounds
|
|
WO2010005520A2
(en)
*
|
2008-06-30 |
2010-01-14 |
Concert Pharmaceuticals, Inc. |
2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives
|
|
WO2010002451A1
(en)
*
|
2008-07-01 |
2010-01-07 |
Concert Pharmaceuticals, Inc. |
Naphthyridin derivatives
|
|
US20100022581A1
(en)
*
|
2008-07-02 |
2010-01-28 |
Memory Pharmaceuticals Corporation |
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
|
|
BRPI0916769A2
(pt)
*
|
2008-07-15 |
2017-09-26 |
Theracos Inc |
derivados de benzilbenzeno deuterados e métodos de uso
|
|
MY156288A
(en)
|
2008-07-16 |
2016-01-29 |
Richter Gedeon Nyrt |
Pharmaceutical formulations containing dopamine receptor ligands.
|
|
US20100093758A1
(en)
*
|
2008-07-23 |
2010-04-15 |
Auspex Pharmaceuticals, Inc. |
Pyridine sulfonamide modulators of endothelin-a receptor
|
|
US20100029629A1
(en)
*
|
2008-07-25 |
2010-02-04 |
Memory Pharmaceuticals Corporation |
Acyclic compounds having 5-ht6 receptor affinity
|
|
MX2011001583A
(es)
|
2008-08-11 |
2011-04-04 |
Nektar Therapeutics |
Conjugados de alcanoato polimericos de multiples brazos.
|
|
US20100221221A1
(en)
*
|
2008-08-12 |
2010-09-02 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
|
WO2010019560A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of donepezil
|
|
US20100056531A1
(en)
*
|
2008-08-22 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
|
US20100074973A1
(en)
*
|
2008-08-27 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Thioxanthene modulators of dopamine d2 receptors
|
|
WO2010025407A1
(en)
|
2008-08-29 |
2010-03-04 |
Concert Pharmaceuticals Inc. |
Substituted triazolo-pyridazine derivatives
|
|
KR20110048571A
(ko)
*
|
2008-09-03 |
2011-05-11 |
테바 파마슈티컬 인더스트리즈 리미티드 |
면역 기능을 지닌 ２―옥소―１,２―다이하이드로―퀴놀린 조절제
|
|
US8704001B2
(en)
|
2008-09-16 |
2014-04-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
|
ES2652289T3
(es)
*
|
2008-09-18 |
2018-02-01 |
Auspex Pharmaceuticals, Inc. |
Derivados deuterados de benzoquinolina como inhibidores del transportador de monoamina vesicular 2
|
|
WO2010033801A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
|
AU2013204067B2
(en)
*
|
2008-09-19 |
2014-02-27 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
|
AU2015258262B2
(en)
*
|
2008-09-19 |
2016-08-18 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
|
WO2010036773A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Deuterated l-aryl-2 -aminomethyl cyclopropane carboxyamide derivatives
|
|
WO2010036796A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Pyridineamine derivatives
|
|
US20100113606A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Aminopropanol modulators of beta-1 adrenergic receptor
|
|
US20100113431A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
N-methyl piperazine modulators of h1 receptor
|
|
WO2010056741A2
(en)
|
2008-11-12 |
2010-05-20 |
Auspex Pharmaceuticals, Inc. |
Phenylacetic acid inhibitors of cyclooxygenase
|
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
US20100137215A1
(en)
*
|
2008-11-25 |
2010-06-03 |
Concert Pharmaceuticals Inc. |
Novel tetrahydro-1h-pyrido[4,3-b]indoles
|
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
|
TWI529172B
(zh)
*
|
2008-12-08 |
2016-04-11 |
吉李德康乃狄克公司 |
作爲脾臟酪胺酸激酶（Ｓｙｋ）抑制劑之咪唑並吡化合物
|
|
NZ593460A
(en)
*
|
2008-12-08 |
2013-11-29 |
Gilead Connecticut Inc |
Imidazopyrazine syk inhibitors
|
|
HU230067B1
(hu)
|
2008-12-17 |
2015-06-29 |
Richter Gedeon Nyrt |
Új piperazin só és eljárás előállítására
|
|
HUP0800766A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Vegyeszet |
Process for the preparation of piperazine derivatives
|
|
HUP0800765A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Nyrt |
A new process for the preparation of piperazine derivatives and their hydrochloric salts
|
|
US20110053961A1
(en)
*
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
|
BRPI1009199A2
(pt)
*
|
2009-03-17 |
2016-03-08 |
Concert Pharmaceuticals Inc |
compostos de pirazinoisoquinolina
|
|
WO2010118291A2
(en)
|
2009-04-10 |
2010-10-14 |
Auspex Pharmaceuticals, Inc. |
Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
|
|
EP3026052A1
(en)
|
2009-04-20 |
2016-06-01 |
Auspex Pharmaceuticals, Inc. |
Preparation of deuterated piperidine inhibitors of janus kinase 3
|
|
AU2010239244B2
(en)
|
2009-04-23 |
2014-02-27 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
WO2010127272A2
(en)
*
|
2009-04-30 |
2010-11-04 |
Concert Pharmaceuticals, Inc. |
Hydroxyethylamino sulfonamide derivatives
|
|
WO2010132810A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Concert Pharmaceuticals, Inc. |
Deuterium modified benzimidazoles
|
|
US8410082B2
(en)
|
2009-05-22 |
2013-04-02 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
|
US20120244122A1
(en)
*
|
2009-05-28 |
2012-09-27 |
Masse Craig E |
Peptides for the Treatment of HCV Infections
|
|
US20110053968A1
(en)
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
|
WO2010147830A2
(en)
|
2009-06-15 |
2010-12-23 |
Auspex Pharmaceuticals, Inc. |
Aminothiazole modulators of beta-3-adrenoreceptor
|
|
US8124646B2
(en)
|
2009-06-18 |
2012-02-28 |
Concert Pharmaceuticals, Inc. |
Substituted isoindoline-1,3-dione derivatives
|
|
EP2454259A1
(en)
|
2009-06-23 |
2012-05-23 |
Concert Pharmaceuticals Inc. |
Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
|
|
CA2768368A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Rigel Pharmaceuticals, Inc. |
Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
|
|
JP2013500347A
(ja)
*
|
2009-07-27 |
2013-01-07 |
オースペックス ファーマシューティカルズ，インク． |
Ｐ２ｙ１２受容体のシクロプロピルモジュレーター
|
|
US8575348B2
(en)
|
2009-07-28 |
2013-11-05 |
Auspex Pharmaceuticals, Inc |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
|
US8637524B2
(en)
|
2009-07-28 |
2014-01-28 |
Auspex Pharmaceuticals, Inc |
Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
|
|
US9512104B2
(en)
|
2009-07-28 |
2016-12-06 |
Auspex Pharmaceuticals, Inc. |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
|
EP2921486B1
(en)
*
|
2009-08-07 |
2017-09-27 |
American Life Science Pharmaceuticals, Inc. |
Compositions and methods for treating beta-amyloid related diseases
|
|
US20110105603A1
(en)
*
|
2010-08-06 |
2011-05-05 |
American Life Science Pharmaceuticals, Inc. |
Compositions and methods for treating beta-amyloid related diseases
|
|
US8530479B2
(en)
*
|
2009-08-10 |
2013-09-10 |
Daljit Singh Dhanoa |
Deuterium-enriched alkyl sulfonamides
|
|
EP2464355A4
(en)
|
2009-08-14 |
2013-01-02 |
Concert Pharmaceuticals Inc |
SUBSTITUTED TRIAZOLPHTHALAZINE DERIVATIVES
|
|
US8658236B2
(en)
|
2009-08-21 |
2014-02-25 |
Deuteria Beverages, Llc |
Alcoholic compositions having a lowered risk of acetaldehydemia
|
|
WO2011028820A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
|
MX2012002704A
(es)
|
2009-09-02 |
2012-03-21 |
Concert Pharmaceuticals Inc |
Derivados de xantina sustituidos.
|
|
CN101666757B
(zh)
*
|
2009-09-25 |
2011-03-16 |
广东省药品检验所 |
中草药降压产品中掺杂二氢吡啶类降压化合物的快筛方法
|
|
RU2012117395A
(ru)
*
|
2009-09-28 |
2013-11-10 |
Ф.Хоффманн-Ля Рош Лтд |
Новые макроциклические ингибиторы репликации вируса гепатита с
|
|
WO2011047315A1
(en)
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Subsitituted benzimidazoles
|
|
WO2011056511A2
(en)
|
2009-10-26 |
2011-05-12 |
Auspex Pharmaceuticals, Inc. |
4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
|
|
KR20120092142A
(ko)
|
2009-10-28 |
2012-08-20 |
애나디스 파마슈티칼스, 인코포레이티드 |
중수소화 5,6-다이하이드로-1ｈ-파이리딘-2-온 화합물
|
|
KR20130028703A
(ko)
*
|
2009-11-04 |
2013-03-19 |
쓰촨 베이라이크 바이오테크놀로지 리미티드 라이어빌러티 컴퍼니 |
결정성 수화물, 이의 약학적 조성물 및 제조 방법 및 용도
|
|
WO2011056764A1
(en)
*
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
|
US8471034B2
(en)
|
2009-11-18 |
2013-06-25 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
US20110152303A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Glaxosmithkline Llc |
Chemical Compounds
|
|
AU2011206864B2
(en)
|
2010-01-15 |
2013-12-19 |
Suzhou Neupharma Co., Ltd. |
Certain chemical entities, compositions, and methods
|
|
EP2536696A1
(en)
*
|
2010-02-18 |
2012-12-26 |
Concert Pharmaceuticals Inc. |
Pyrimidine derivatives
|
|
US8513434B2
(en)
|
2010-03-02 |
2013-08-20 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
CN103168039B
(zh)
|
2010-03-11 |
2016-08-03 |
吉利德康涅狄格公司 |
咪唑并吡啶类syk抑制剂
|
|
WO2011116066A1
(en)
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
CN104744456A
(zh)
*
|
2010-06-01 |
2015-07-01 |
奥斯拜客斯制药有限公司 |
Vmat2的苯并喹啉酮抑制剂
|
|
WO2012006070A1
(en)
*
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
GB2495884B
(en)
|
2010-07-15 |
2017-05-31 |
Iliich Epshtein Oleg |
A method of increasing the effect of an activated-potentiated form of an antibody
|
|
JP2013532182A
(ja)
|
2010-07-15 |
2013-08-15 |
イリイチ・エプシテイン オレグ |
組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法
|
|
PH12013500108A1
(en)
|
2010-07-15 |
2017-01-06 |
Oleg Iliich Epshtein |
Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
|
|
WO2012009446A1
(en)
|
2010-07-16 |
2012-01-19 |
Concert Pharmaceuticals Inc. |
Novel pyrimidinecarboxamide derivatives
|
|
GB2496343B
(en)
|
2010-07-21 |
2017-11-01 |
Iliich Epshtein Oleg |
A method of treating attention deficit hyperactivity disorder
|
|
WO2012024893A1
(en)
|
2010-08-23 |
2012-03-01 |
Suzhou Neupharma Co., Ltd. |
Certain chemical entities, compositions, and methods
|
|
WO2012027957A1
(en)
|
2010-08-28 |
2012-03-08 |
Suzhou Neupharma Co., Ltd. |
Bufalin derivatives, pharmaceutical compositions and use thereof
|
|
WO2012031073A1
(en)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
WO2012031072A1
(en)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
KR20140027907A
(ko)
|
2010-10-11 |
2014-03-07 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
치환된 벤즈아미드 및 그의 용도
|
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
|
EP3453714B1
(en)
|
2011-02-02 |
2020-11-04 |
Suzhou Neupharma Co., Ltd |
Cardenolide and bufadienolide 3-carbonate and 3-carbamate derivatives for the treatment of cancer and compositions thereof
|
|
JP2014513046A
(ja)
|
2011-02-14 |
2014-05-29 |
コンサート ファーマシューティカルズ インコーポレイテッド |
４−ヒドロキシ酪酸の重水素化類似体
|
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
WO2012122028A2
(en)
|
2011-03-04 |
2012-09-13 |
Concert Pharmaceuticals Inc. |
Pyrazinoisoquinoline compounds
|
|
AU2012225611B2
(en)
|
2011-03-08 |
2016-09-15 |
Auspex Pharmaceuticals, Inc. |
Substituted N-Aryl pyridinones
|
|
US9090585B2
(en)
|
2011-03-28 |
2015-07-28 |
Deuterx, Llc |
2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
|
|
DK2705013T3
(en)
*
|
2011-05-04 |
2016-07-18 |
Balance Therapeutics Inc |
Pentylenetetrazolderivater
|
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
|
LT2709986T
(lt)
*
|
2011-05-18 |
2017-05-25 |
Concert Pharmaceuticals Inc. |
Ivakaftoro deuterinti dariniai
|
|
US8691808B2
(en)
|
2011-05-20 |
2014-04-08 |
Influmedix, Inc. |
Antiviral compounds and their methods of use
|
|
CA2834920A1
(en)
*
|
2011-05-23 |
2012-11-29 |
Sanofi |
Process for the preparation of deuterated compounds containing n-alkyl groups
|
|
US8778223B2
(en)
|
2011-05-24 |
2014-07-15 |
Lc Vision, Llc |
Liquid crystals having cyclohexyl core structures and fluorinated tails
|
|
JP6023800B2
(ja)
|
2011-06-17 |
2016-11-09 |
アストラゼネカ アクチボラグ |
ｔｒａｎｓ−７−オキソ−６−（スルホオキシ）−１，６−ジアザビシクロ［３，２，１］オクタン−２−カルボキサミドとその塩が含まれる複素環式化合物を製造するための方法
|
|
SMT201900179T1
(it)
*
|
2011-06-20 |
2019-05-10 |
H Lundbeck As |
1–piperazino–3–fenil indani deuterati per il trattamento della schizofrenia
|
|
WO2013032951A1
(en)
|
2011-08-26 |
2013-03-07 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP2753174A4
(en)
|
2011-09-01 |
2015-05-20 |
Xiangping Qian |
PARTICULAR CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
|
|
EP2755657B1
(en)
|
2011-09-14 |
2017-11-29 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP2757885B1
(en)
|
2011-09-21 |
2017-03-15 |
Neupharma, Inc. |
Certain chemical entites, compositions, and methods
|
|
US9249111B2
(en)
|
2011-09-30 |
2016-02-02 |
Neupharma, Inc. |
Substituted quinoxalines as B-RAF kinase inhibitors
|
|
CN106479990B
(zh)
|
2011-11-18 |
2020-09-18 |
科德克希思公司 |
用于制备羟基取代的氨基甲酸酯的生物催化剂
|
|
RU2681835C2
(ru)
|
2012-01-23 |
2019-03-13 |
Сейдж Терапьютикс, Инк. |
Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс
|
|
WO2013112950A2
(en)
|
2012-01-25 |
2013-08-01 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
WO2013132263A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Axelar Ab |
Picropodophyllin derivatives for use in therapy
|
|
BR112014024693A2
(pt)
|
2012-04-05 |
2017-07-11 |
Chdi Foundation Inc |
composto de fórmula / ou um sal farmaceuticamente aceitável ou pró-fármaco do mesmo; composto; composição farmacêutica; método de tratamento de uma afecção ou distúrbio mediado por atividade de quinurenina 3-mono-oxigenase em um indivíduo que necessita de tal tratamento
|
|
SG10201509063SA
(en)
|
2012-04-12 |
2015-12-30 |
Univ Leland Stanford Junior |
Substituted benzamides and their uses
|
|
KR20150002779A
(ko)
|
2012-04-13 |
2015-01-07 |
콘서트 파마슈티컬즈, 인크. |
치환된 크산틴 유도체
|
|
EP2838879A1
(en)
|
2012-04-20 |
2015-02-25 |
Concert Pharmaceuticals Inc. |
Deuterated rigosertib
|
|
WO2013165924A1
(en)
|
2012-04-29 |
2013-11-07 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
RS67061B1
(sr)
|
2012-06-15 |
2025-08-29 |
Sun Pharmaceutical Industries Inc |
Deuterisani derivati ruksolitiniba
|
|
CN102757417B
(zh)
*
|
2012-06-18 |
2014-09-24 |
中国科学院广州生物医药与健康研究院 |
氘代苯并吡喃类化合物及其应用
|
|
US9181190B2
(en)
|
2012-07-04 |
2015-11-10 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
|
US10017445B2
(en)
|
2012-07-12 |
2018-07-10 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
|
CN104507946A
(zh)
|
2012-07-30 |
2015-04-08 |
康塞特医药品有限公司 |
氘代依鲁替尼
|
|
GB201214169D0
(en)
|
2012-08-08 |
2012-09-19 |
Biostatus Ltd |
New compounds and uses thereof
|
|
WO2014028756A1
(en)
|
2012-08-17 |
2014-02-20 |
Concert Pharmaceuticals, Inc. |
Deuterated baricitinib
|
|
IL294306B2
(en)
|
2012-08-21 |
2024-01-01 |
Sage Therapeutics Inc |
Methods of treating epilepsy or status epilepticus
|
|
CN113679717A
(zh)
|
2012-08-22 |
2021-11-23 |
康奈尔大学 |
用于抑制肌成束蛋白的方法
|
|
CN116768882A
(zh)
|
2012-09-18 |
2023-09-19 |
奥斯拜客斯制药有限公司 |
化合物、及其药物组合物及治疗方法
|
|
US9550780B2
(en)
|
2012-09-18 |
2017-01-24 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
WO2014047648A1
(en)
|
2012-09-24 |
2014-03-27 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
WO2014066243A1
(en)
|
2012-10-22 |
2014-05-01 |
Concert Pharmaceuticals, Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
|
|
US9725421B2
(en)
|
2012-11-12 |
2017-08-08 |
Neupharma, Inc. |
Substituted quinoxalines as B-raf kinase inhibitors
|
|
JP6146990B2
(ja)
*
|
2012-11-16 |
2017-06-14 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたｃｆｔｒ増強物質
|
|
CN103833630B
(zh)
*
|
2012-11-21 |
2018-11-13 |
顶点制药（欧洲）有限公司 |
氘化cftr增效剂
|
|
MX2015008187A
(es)
*
|
2012-12-20 |
2016-02-05 |
Concert Pharmaceuticals Inc |
Inhibidores de alk deuterados.
|
|
US9518027B2
(en)
|
2013-01-09 |
2016-12-13 |
Concert Pharmaceuticals, Inc. |
Deuterated momelotinib
|
|
US9540340B2
(en)
|
2013-01-14 |
2017-01-10 |
Deuterx, Llc |
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
|
|
EA201500801A1
(ru)
*
|
2013-01-31 |
2016-01-29 |
Ауспекс Фармацетикалс, Инк. |
Бензохинолоновые ингибиторы vmat2
|
|
GB201302368D0
(en)
*
|
2013-02-11 |
2013-03-27 |
Univ Bath |
Compound
|
|
CA2941562C
(en)
|
2013-03-14 |
2021-09-21 |
Deuterx, Llc |
Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
|
|
CA2941560A1
(en)
|
2013-03-14 |
2014-09-25 |
Deuterx, Llc |
3-(substituted-4-oxo-quinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
|
|
EP2968268B1
(en)
|
2013-03-15 |
2020-07-29 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
|
WO2014145325A1
(en)
|
2013-03-15 |
2014-09-18 |
Protia, Llc |
Deuterium-enriched aldehydes
|
|
CN104109149B
(zh)
*
|
2013-04-22 |
2018-09-28 |
苏州泽璟生物制药有限公司 |
氘代的二氨基嘧啶化合物以及包含该化合物的药物组合物
|
|
ES2822285T3
(es)
|
2013-07-30 |
2021-04-30 |
Kronos Bio Inc |
Polimorfo de inhibidores de SYK
|
|
KR20160036590A
(ko)
|
2013-07-30 |
2016-04-04 |
질레드 코네티컷 인코포레이티드 |
Ｓｙｋ 억제제의 제제
|
|
SG11201601138PA
(en)
|
2013-08-23 |
2016-03-30 |
Neupharma Inc |
Certain chemical entities, compositions, and methods
|
|
US9676790B2
(en)
|
2013-08-30 |
2017-06-13 |
Concert Pharmaceuticals, Inc. |
Substituted thienotriazolodiazapines
|
|
MX369956B
(es)
|
2013-12-03 |
2019-11-27 |
Auspex Pharmaceuticals Inc |
Metodos para preparar compuestos de benzoquinolina.
|
|
PL3076967T3
(pl)
|
2013-12-03 |
2021-12-20 |
Intra-Cellular Therapies, Inc. |
Metody leczenia objawów rezydualnych schizofrenii
|
|
MX2016007311A
(es)
|
2013-12-04 |
2016-09-07 |
Gilead Sciences Inc |
Metodos para tratar canceres.
|
|
WO2015095713A1
(en)
*
|
2013-12-20 |
2015-06-25 |
Deuterx, Llc |
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
|
|
TWI735853B
(zh)
|
2013-12-23 |
2021-08-11 |
美商克洛諾斯生技有限公司 |
脾酪胺酸激酶抑制劑
|
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
|
BR112016015449A8
(pt)
|
2013-12-30 |
2020-06-09 |
Lifesci Pharmaceuticals Inc |
compostos inibidores terapêuticos, composição farmacêutica os compreendendo e uso dos mesmos
|
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
EP3094328B1
(en)
|
2014-01-15 |
2020-08-19 |
Poxel SA |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
|
WO2015120393A1
(en)
|
2014-02-10 |
2015-08-13 |
Concert Pharmaceuticals, Inc. |
Substituted triazolobenzodiazepines
|
|
US9573946B2
(en)
|
2014-02-20 |
2017-02-21 |
Novita Pharmaceuticals, Inc. |
Compounds and methods for inhibiting fascin
|
|
MX388258B
(es)
|
2014-04-04 |
2025-03-19 |
Intra Cellular Therapies Inc |
Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
|
|
US9884872B2
(en)
*
|
2014-06-20 |
2018-02-06 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
CN106687139A
(zh)
|
2014-07-14 |
2017-05-17 |
吉利德科学公司 |
用于治疗癌症的组合
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
SI3193611T1
(sl)
|
2014-09-17 |
2021-08-31 |
Celgene Car Llc |
Inhibitorji MK2 in njihove uporabe
|
|
EP3212656B1
(en)
|
2014-10-27 |
2019-06-05 |
Concert Pharmaceuticals Inc. |
Pyrimidine phosphonic acid esters bearing at least one deuterium atom
|
|
JP2017533911A
(ja)
*
|
2014-10-29 |
2017-11-16 |
センター ラボラトリーズ， インク．Ｃｅｎｔｅｒ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． |
ベラパミル塩酸塩の結晶型
|
|
KR20170094184A
(ko)
|
2014-11-06 |
2017-08-17 |
이난타 파마슈티칼스, 인코포레이티드 |
Fxr/tgr5 작용제로서의 담즙산 유사체 및 이의 이용 방법
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
WO2016086115A1
(en)
|
2014-11-26 |
2016-06-02 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
|
|
WO2016116059A1
(zh)
*
|
2015-01-22 |
2016-07-28 |
高雄医学大学 |
用于治疗代谢症候群的组合物及其制备方法
|
|
CN105985396A
(zh)
*
|
2015-02-16 |
2016-10-05 |
苏州泽璟生物制药有限公司 |
氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物
|
|
CN107613769A
(zh)
|
2015-02-17 |
2018-01-19 |
润新生物公司 |
某些化学实体、组合物和方法
|
|
US20160287574A1
(en)
|
2015-03-06 |
2016-10-06 |
Auspex Pharmaceuticals, Inc. |
Methods for the treatment of abnormal involuntary movement disorders
|
|
ES2886766T3
(es)
|
2015-03-31 |
2021-12-20 |
Enanta Pharm Inc |
Derivados del ácido biliar como agonistas de FXR/TGR5 y métodos de uso de estos
|
|
US10196384B2
(en)
|
2015-03-31 |
2019-02-05 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated CFTR modulators
|
|
US20180311258A1
(en)
*
|
2015-04-10 |
2018-11-01 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
|
CN106279039B
(zh)
*
|
2015-06-02 |
2019-01-11 |
青岛海洋生物医药研究院股份有限公司 |
氘代脱氢苯基阿夕斯丁类化合物及其制备方法和在制备抗肿瘤的药物中的应用
|
|
EP3317259A4
(en)
|
2015-07-01 |
2019-06-12 |
Lifesci Pharmaceuticals, Inc. |
THERAPEUTIC INHIBITING COMPOUNDS
|
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
|
CA2999529A1
(en)
|
2015-09-25 |
2017-03-30 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated cftr potentiators
|
|
ES2909122T3
(es)
|
2015-11-09 |
2022-05-05 |
Forge Therapeutics Inc |
Compuestos a base de hidroxipiridinona e hidroxipirimidinona para el tratamiento de infecciones bacterianas
|
|
WO2017087795A1
(en)
|
2015-11-19 |
2017-05-26 |
Concert Pharmaceuticals, Inc. |
Deuterated epi-743
|
|
EP3386536A4
(en)
|
2015-12-07 |
2019-07-31 |
Opi Vi- IP Holdco LLC |
COMPOSITION OF ANTIBODY CONSTRUCT AGONIST CONJUGATES AND METHOD FOR USE THEREOF
|
|
CN106892924B
(zh)
*
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
|
US10442761B2
(en)
|
2016-02-16 |
2019-10-15 |
Concert Pharmaceuticals, Inc. |
Deuterated GFT-505
|
|
WO2017147159A1
(en)
*
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
US11147802B2
(en)
|
2016-02-25 |
2021-10-19 |
Shenzhen Targetrx, Inc. |
Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereof
|
|
KR20220084418A
(ko)
|
2016-03-08 |
2022-06-21 |
세이지 테라퓨틱스, 인크. |
신경활성 스테로이드, 조성물, 및 그의 용도
|
|
PL3407889T3
(pl)
|
2016-03-25 |
2021-11-22 |
Intra-Cellular Therapies, Inc. |
Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego
|
|
US11274087B2
(en)
|
2016-07-08 |
2022-03-15 |
Richter Gedeon Nyrt. |
Industrial process for the preparation of cariprazine
|
|
EP3481391A4
(en)
|
2016-07-11 |
2020-03-11 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
CA3033370A1
(en)
|
2016-08-15 |
2018-02-22 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
ES2861498T3
(es)
*
|
2016-09-29 |
2021-10-06 |
Jiangsu Jibeier Pharmaceutical Co Ltd |
Derivado de 1-[(piridin-3-yl-sulfonil)-1h-pirrol-3-yl]metanamina y composición farmacéutica y uso del mismo
|
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
|
JP2017105824A
(ja)
*
|
2017-02-10 |
2017-06-15 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたｃｆｔｒ増強物質
|
|
SG10202110184XA
(en)
|
2017-03-15 |
2021-10-28 |
Silverback Therapeutics Inc |
Benzazepine compounds, conjugates, and uses thereof
|
|
US11098057B2
(en)
|
2017-03-16 |
2021-08-24 |
Celgene Car Llc |
9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno[3,2-F]quinolin-8-one compounds and uses thereof
|
|
WO2018170201A1
(en)
|
2017-03-16 |
2018-09-20 |
Celgene Car Llc |
Deuterated analogs of mk2 inhibitors and uses thereof
|
|
JP7200120B2
(ja)
|
2017-03-16 |
2023-01-06 |
セルジーン シーエーアール エルエルシー |
Ｍｋ２阻害剤として有用なヘテロアリール化合物
|
|
KR20240141212A
(ko)
|
2017-03-24 |
2024-09-25 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 조성물 및 방법
|
|
WO2018208985A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2018223065A1
(en)
|
2017-06-01 |
2018-12-06 |
Xoc Pharmaceuticals, Inc. |
Ergoline derivatives for use in medicine
|
|
CN107226769A
(zh)
*
|
2017-06-19 |
2017-10-03 |
郑州泰基鸿诺医药股份有限公司 |
一种含二氟氘代甲氧（硫）基官能团的芳香类化合物的合成方法
|
|
CN109422731A
(zh)
*
|
2017-08-24 |
2019-03-05 |
正大天晴药业集团股份有限公司 |
氘代喹啉衍生物
|
|
US11384082B2
(en)
|
2017-08-25 |
2022-07-12 |
Kronos Bio, Inc. |
Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors
|
|
CN108947974B
(zh)
*
|
2017-08-30 |
2020-06-05 |
深圳市塔吉瑞生物医药有限公司 |
一种氨基嘧啶类化合物及包含该化合物的组合物及其用途
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
AU2018359336B2
(en)
|
2017-11-03 |
2024-06-20 |
Nirsum Laboratories, Inc. |
Opioid receptor antagonist prodrugs
|
|
US12116348B2
(en)
|
2017-11-14 |
2024-10-15 |
Shenzhen Targetrx, Inc. |
Substituted benzimidazole compound and composition comprising same
|
|
US20200368193A1
(en)
|
2017-11-22 |
2020-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of d-serine and uses thereof
|
|
IL305169B2
(en)
|
2017-12-01 |
2025-07-01 |
Vertex Pharma |
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
|
|
JP2021505608A
(ja)
*
|
2017-12-08 |
2021-02-18 |
セージ セラピューティクス， インコーポレイテッド |
ＣＮＳ障害を処置するためのジュウテリウム化された２１−［４−シアノ−ピラゾール−１−イル］−１９−ノル−プレガン−３．α−オール−２０−オン誘導体
|
|
US12440477B2
(en)
|
2017-12-14 |
2025-10-14 |
Nmd Pharma A/S |
Compounds for the treatment of neuromuscular disorders
|
|
TWI780281B
(zh)
*
|
2017-12-14 |
2022-10-11 |
丹麥商Ｎｍｄ藥品公司 |
用於治療神經肌肉病症的化合物
|
|
AU2018385693A1
(en)
|
2017-12-15 |
2020-06-18 |
Silverback Therapeutics, Inc. |
Antibody construct-drug conjugate for the treatment of hepatitis
|
|
CN109456331B
(zh)
|
2017-12-22 |
2020-06-05 |
深圳市塔吉瑞生物医药有限公司 |
一种取代的吡唑并[1,5-a]嘧啶化合物及其药物组合物及用途
|
|
EP3740481B9
(en)
|
2018-01-19 |
2024-10-23 |
Cytokinetics, Inc. |
Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
|
|
EP3744723B1
(en)
|
2018-01-23 |
2023-10-18 |
Shenzhen TargetRx, Inc. |
Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound
|
|
EP3746430A4
(en)
|
2018-02-02 |
2021-11-03 |
Padforward LLC |
INHIBITORS OF PROTEIN ARGININE DEIMINASES
|
|
CA3090528A1
(en)
|
2018-02-08 |
2019-08-15 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
IL277335B2
(en)
*
|
2018-03-21 |
2024-03-01 |
Izumi Tech Llc |
Analogues of alcridar with deuterium
|
|
WO2019195278A1
(en)
|
2018-04-02 |
2019-10-10 |
Silverback Therapeutics, Inc. |
Alk5 inhibitors, conjugates, and uses thereof
|
|
EP3787629A4
(en)
|
2018-05-02 |
2022-01-05 |
Kinnate Biopharma Inc. |
CYCLINE-DEPENDENT KINASE INHIBITORS
|
|
US12258324B2
(en)
|
2018-05-16 |
2025-03-25 |
Lin Bioscience Pty Ltd. |
Fatty acid analogues and methods of use
|
|
BR112020023926A2
(pt)
|
2018-05-25 |
2021-02-17 |
Silverback Therapeutics, Inc. |
compostos de amino-pirazinocarboxamida, conjugados e usos dos mesmos
|
|
US11964967B2
(en)
|
2018-06-26 |
2024-04-23 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
|
WO2020005888A1
(en)
|
2018-06-26 |
2020-01-02 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
|
CA3104131A1
(en)
|
2018-06-29 |
2020-01-02 |
Kinnate Biopharma Inc. |
Inhibitors of cyclin-dependent kinases
|
|
JP6654223B2
(ja)
*
|
2018-08-13 |
2020-02-26 |
バーテックス ファーマシューティカルズ （ヨーロッパ） リミテッド |
重水素化されたｃｆｔｒ増強物質
|
|
CN109020875B
(zh)
*
|
2018-08-27 |
2020-05-22 |
北京市药品检验所 |
二氢吡啶类化合物脱氢芳构化方法及在药品检测中的用途
|
|
EP3843729A4
(en)
|
2018-08-29 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NEW COMPOSITIONS AND METHODS
|
|
EP3843842A1
(en)
|
2018-08-31 |
2021-07-07 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
|
WO2020047407A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
CN118873536A
(zh)
|
2018-08-31 |
2024-11-01 |
细胞内治疗公司 |
新方法
|
|
KR20210065958A
(ko)
*
|
2018-09-05 |
2021-06-04 |
루핀 인코포레이티드 |
세균성 질증의 치료에 사용하기 위한 중수소화된 세크니다졸 및 이의 방법 및 용도
|
|
WO2020056198A2
(en)
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Substituted benzazepine compounds, conjugates, and uses thereof
|
|
WO2020056194A1
(en)
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Benzazepine compounds, conjugates, and uses thereof
|
|
JP2022500414A
(ja)
|
2018-09-12 |
2022-01-04 |
シルバーバック セラピューティックス インコーポレイテッド |
免疫刺激性コンジュゲートにより疾患を処置する方法および組成物
|
|
SG11202102712WA
(en)
|
2018-09-20 |
2021-04-29 |
Forge Therapeutics Inc |
Antibacterial compounds
|
|
CN113194977A
(zh)
|
2018-10-16 |
2021-07-30 |
格罗制药公司 |
烟碱乙酰胆碱受体肽拮抗剂芋螺毒素组合物及相关方法
|
|
AU2019376065B2
(en)
|
2018-11-06 |
2025-03-06 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
DK3877052T3
(da)
|
2018-11-06 |
2023-09-25 |
Edgewise Therapeutics Inc |
Pyridazinonforbindelser og anvendelser deraf
|
|
WO2020097258A1
(en)
|
2018-11-06 |
2020-05-14 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
EP3891134A1
(en)
|
2018-12-03 |
2021-10-13 |
H. Lundbeck A/S |
Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine
|
|
AR117228A1
(es)
*
|
2018-12-06 |
2021-07-21 |
Arisan Therapeutics |
DERIVADOS DE PIRAZOLO[1,2-a]PIRIDINA, 1H-BENZO[d][1,2,3]TRIAZOL, IMIDAZOPIRIMIDINA Y BENCIMIDAZOL PARA USAR EN EL TRATAMIENTO DE LA INFECCIÓN POR ARENAVIRUS
|
|
IL319687A
(en)
|
2018-12-06 |
2025-05-01 |
Intrabio Ltd |
Deuterated acetyl-leucine analogs
|
|
CA3121636A1
(en)
|
2018-12-17 |
2020-06-25 |
Intra-Cellular Therapies, Inc. |
Analogs of (3alpha,5alpha)-3-hydroxy-21-(1h-imidazol-1-yl)-3-methoxymethyl)-pregnan-20-one
|
|
CN113766916B
(zh)
|
2019-01-22 |
2024-04-05 |
艾奥维安制药公司 |
Mtorc调节剂及其用途
|
|
JP2022521730A
(ja)
|
2019-02-19 |
2022-04-12 |
ウルティマ・ゲノミクス・インコーポレーテッド |
光検出および配列決定のためのリンカーおよび方法
|
|
CA3130848A1
(en)
|
2019-02-22 |
2020-08-27 |
Kronos Bio, Inc. |
Solid forms of condensed pyrazines as syk inhibitors
|
|
WO2020181040A1
(en)
|
2019-03-06 |
2020-09-10 |
Silverback Therapeutics, Inc. |
Cyclic amino-pyrazinecarboxamide compounds and uses thereof
|
|
WO2020206367A1
(en)
|
2019-04-03 |
2020-10-08 |
Concert Pharmaceuticals, Inc. |
Processes for the preparation of deuterated d-serine
|
|
US11547707B2
(en)
|
2019-04-10 |
2023-01-10 |
Richter Gedeon Nyrt. |
Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
|
|
EP3955926A4
(en)
|
2019-04-18 |
2022-11-30 |
Azura Ophthalmics Ltd. |
Compounds and methods for the treatment of ocular disorders
|
|
KR20210154214A
(ko)
|
2019-04-18 |
2021-12-20 |
아주라 오프탈믹스 엘티디 |
안구 질병의 치료를 위한 화합물 및 방법
|
|
AR118826A1
(es)
|
2019-05-03 |
2021-11-03 |
Kinnate Biopharma Inc |
Inhibidores de cinasas raf
|
|
WO2020226628A1
(en)
|
2019-05-07 |
2020-11-12 |
Nirsum Laboratories, Inc. |
Opioid receptor antagonist prodrugs for treating opioid dependence
|
|
WO2020247546A1
(en)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
|
WO2020247540A1
(en)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
|
EP4134101A1
(en)
|
2019-07-07 |
2023-02-15 |
Intra-Cellular Therapies, Inc. |
Deuterated lumateperone for the treatment of the bipolar ii disorder
|
|
JP2022540818A
(ja)
|
2019-07-08 |
2022-09-20 |
ビーライト バイオ，エルエルシー |
Ｒｂｐ４阻害剤の製剤および使用の方法
|
|
CA3146661A1
(en)
|
2019-07-16 |
2021-01-21 |
Silverback Therapeutics, Inc. |
Alk5 inhibitors, conjugates, and uses thereof
|
|
JP7612672B2
(ja)
|
2019-09-03 |
2025-01-14 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
新規化合物
|
|
CA3154608A1
(en)
|
2019-09-16 |
2021-03-25 |
Dice Alpha, Inc. |
Il-17a modulators and uses thereof
|
|
WO2021067644A1
(en)
|
2019-10-01 |
2021-04-08 |
Silverback Therapeutics, Inc. |
Combination therapy with immune stimulatory conjugates
|
|
CN114945560B
(zh)
|
2019-10-07 |
2024-08-13 |
卡尔优普公司 |
Gpr119激动剂
|
|
WO2021072203A1
(en)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
Tgfbetar1 inhibitor-asgr antibody conjugates and uses thereof
|
|
WO2021072330A1
(en)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
Galnac-tgfbr1 inhibitor conjugates for the treatment of liver diseases
|
|
CN114845711B
(zh)
|
2019-10-24 |
2024-10-01 |
皮埃尔法布雷医药公司 |
Raf激酶的抑制剂
|
|
WO2021102332A1
(en)
|
2019-11-22 |
2021-05-27 |
Silverback Therapeutics, Inc. |
Tgfbetar2 inhibitor-lrrc15 antibody conjugates and uses thereof
|
|
US11752149B2
(en)
|
2019-12-02 |
2023-09-12 |
Pipeline Therapeutics, Inc. |
Muscarinic acetylcholine M1 receptor antagonists
|
|
US20230038929A1
(en)
|
2019-12-05 |
2023-02-09 |
Verge Analytics, Inc. |
Fused Tricyclic Heterocyclic Compounds and Uses Thereof
|
|
IL294504A
(en)
|
2020-01-13 |
2022-09-01 |
Verge Analytics Inc |
Converted pyrazolo-pyrimidines and their uses
|
|
CN115515934B
(zh)
|
2020-02-07 |
2025-10-17 |
赛特凯恩蒂克公司 |
Nampt调节剂
|
|
US11807851B1
(en)
|
2020-02-18 |
2023-11-07 |
Ultima Genomics, Inc. |
Modified polynucleotides and uses thereof
|
|
JP7735291B2
(ja)
|
2020-02-21 |
2025-09-08 |
エーアールエス ファーマシューティカルズ、インコーポレイテッド |
ネクチン－４抗体コンジュゲートおよびその使用
|
|
CN115667277A
(zh)
|
2020-02-28 |
2023-01-31 |
卡尔优普公司 |
Gpr40激动剂
|
|
TW202140496A
(zh)
|
2020-03-09 |
2021-11-01 |
美商邊際分析公司 |
經取代嘧啶及其用途
|
|
US11731962B2
(en)
|
2020-03-25 |
2023-08-22 |
Blacksmith Medicines, Inc. |
LpxC inhibitor and methods of making
|
|
WO2021195425A1
(en)
*
|
2020-03-26 |
2021-09-30 |
Sinopia Biosciences, Inc. |
Isotopically-labelled trapidil derivatives
|
|
EP4146344A1
(en)
|
2020-05-04 |
2023-03-15 |
Volastra Therapeutics, Inc. |
Imino sulfanone inhibitors of enpp1
|
|
WO2021226276A2
(en)
|
2020-05-06 |
2021-11-11 |
Cytokinetics, Inc. |
Nampt modulators
|
|
JP7606537B2
(ja)
|
2020-05-13 |
2024-12-25 |
エッジワイズ セラピューティクス， インコーポレイテッド |
神経筋疾患の処置のためのピリダジノン化合物
|
|
EP4149465A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
WO2021231572A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds for the treatment of neuromuscular diseases
|
|
WO2021231630A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
WO2021231615A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
CA3178372A1
(en)
|
2020-05-14 |
2021-11-18 |
Roland D. Saito |
Enpp1 modulators and uses thereof
|
|
UY39222A
(es)
|
2020-05-19 |
2021-11-30 |
Kallyope Inc |
Activadores de la ampk
|
|
CA3181162A1
(en)
|
2020-06-05 |
2021-12-09 |
Stephen W. Kaldor |
Inhibitors of fibroblast growth factor receptor kinases
|
|
TW202214640A
(zh)
|
2020-06-16 |
2022-04-16 |
美商佛拉斯托醫療公司 |
Ｅｎｐｐ１之雜環抑制劑
|
|
CA3183575A1
(en)
|
2020-06-26 |
2021-12-30 |
Iyassu Sebhat |
Ampk activators
|
|
US11767317B1
(en)
|
2020-06-30 |
2023-09-26 |
Poxel Sa |
Methods of synthesizing enantiopure deuterium-enriched pioglitazone
|
|
US11319313B2
(en)
|
2020-06-30 |
2022-05-03 |
Poxel Sa |
Crystalline forms of deuterium-enriched pioglitazone
|
|
CA3183993A1
(en)
|
2020-07-01 |
2022-01-06 |
Peter R. Baum |
Anti-asgr1 antibody conjugates and uses thereof
|
|
EP4185590A2
(en)
|
2020-07-21 |
2023-05-31 |
Aeovian Pharmaceuticals, Inc. |
Mtorc1 modulators and uses thereof
|
|
WO2022040241A1
(en)
|
2020-08-17 |
2022-02-24 |
Biointervene, Inc. |
A3 adenosine receptor agonists for use in medicine
|
|
WO2022040213A1
(en)
|
2020-08-18 |
2022-02-24 |
Ultima Genomics, Inc. |
Reagents for labeling biomolecules
|
|
TWI788977B
(zh)
*
|
2020-08-27 |
2023-01-01 |
南韓商Ｌｇ化學股份有限公司 |
生產氘化芳香族化合物的方法、氘化反應組成物、氘化芳香族化合物以及電子裝置
|
|
KR102666349B1
(ko)
*
|
2020-08-27 |
2024-05-16 |
주식회사 엘지화학 |
중수소화 방향족 화합물의 제조 방법 및 중수소화 반응 조성물
|
|
CN111995574B
(zh)
*
|
2020-08-28 |
2024-05-17 |
西安明喆药品生产有限公司 |
氘代羟氯喹衍生物以及包含该化合物的药物组合物
|
|
AU2021331624A1
(en)
|
2020-08-31 |
2023-05-04 |
Visus Therapeutics, Inc. |
Compounds and formulations for treating ophthalmic diseases
|
|
US11407737B2
(en)
|
2020-09-18 |
2022-08-09 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
|
WO2022072652A1
(en)
|
2020-09-30 |
2022-04-07 |
Ultima Genomics, Inc. |
Methods, systems, and apparatus for high throughput sequencing
|
|
AU2021361938A1
(en)
*
|
2020-10-12 |
2023-05-25 |
Systimmune, Inc. |
Deuterated camptothecin derivative and antibody-drug conjugate thereof
|
|
US11377431B2
(en)
|
2020-10-12 |
2022-07-05 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
|
US11981644B2
(en)
|
2020-11-06 |
2024-05-14 |
Cytokinetics, Inc. |
Bicyclic 1,4-diazepanones and therapeutic uses thereof
|
|
US12522589B2
(en)
|
2020-11-13 |
2026-01-13 |
Calcimedica, Inc. |
Synthesis of CRAC channel inhibitors
|
|
EP4249473A4
(en)
*
|
2020-11-17 |
2024-10-09 |
Ningbo Combireg Pharmaceutical Technology Co., Ltd |
DEUTERATED 1,4-BENZODIAZEPINE-2,5-DIONE COMPOUND AND ITS USE
|
|
WO2022106902A2
(en)
|
2020-11-20 |
2022-05-27 |
2692372 Ontario, Inc. |
Benzenesulfonamide derivatives and uses thereof
|
|
CN116745264A
(zh)
|
2020-11-20 |
2023-09-12 |
2692372安大略公司 |
用于kras修饰的方法和组合物
|
|
WO2022140290A1
(en)
|
2020-12-21 |
2022-06-30 |
Cytokinetics, Inc. |
Pyrazole derivatives useful as nampt modulators
|
|
WO2022169882A1
(en)
|
2021-02-03 |
2022-08-11 |
Verge Analytics, Inc. |
Methods and treatment of viral infection caused by sars-cov-2
|
|
WO2022179528A1
(en)
|
2021-02-24 |
2022-09-01 |
Insilico Medicine Ip Limited |
Analogs for the treatment of disease
|
|
CA3209557A1
(en)
|
2021-03-04 |
2022-09-09 |
Bradley P. Morgan |
Cardiac sarcomere inhibitors
|
|
EP4313100A4
(en)
|
2021-03-24 |
2025-10-15 |
Glo Pharma Inc |
PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION
|
|
EP4314324A4
(en)
|
2021-03-30 |
2025-03-05 |
Ultima Genomics, Inc. |
CLEAVABLE BINDERS FORMING BENIGN SCARS
|
|
US11459351B1
(en)
|
2021-04-05 |
2022-10-04 |
Azura Ophthalmics Ltd. |
Compounds and methods for the treatment of ocular disorders
|
|
EP4320103A1
(en)
|
2021-04-09 |
2024-02-14 |
Quanta Therapeutics, Inc. |
Pyrimidine based ras modulators and uses thereof
|
|
JP2024516174A
(ja)
*
|
2021-04-23 |
2024-04-12 |
ギルガメッシュ・ファーマシューティカルズ・インコーポレイテッド |
新規エルゴリン及び気分障害を処置する方法
|
|
AU2022261117A1
(en)
|
2021-04-23 |
2023-11-23 |
Pierre Fabre Medicament |
Treatment of cancer with a raf inhibitor
|
|
WO2022256297A1
(en)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
2-(3-phenyl-1h-pyrazol-1-yl)-4-morpholino-5h-pyrrolo[3,2-d]pyrimidine derivatives and similar compounds as pikfyve kinase inhibitors for the treatment of e.g. amyotrophic lateral sclerosis (als)
|
|
AR126013A1
(es)
|
2021-06-01 |
2023-08-30 |
Verge Analytics Inc |
Compuestos heterocíclicos bicíclicos fusionados y usos de los mismos
|
|
WO2022256298A1
(en)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
7-(3-phenyl-1 h-pyrazol-1-yl)-5-morpholino-imidazo[1,2-a]pyrimidine derivatives and similar compounds as pikfyve kinase inhibitors for the treatment of e.g. amyotrophic lateral sclerosis (als)
|
|
TW202313626A
(zh)
|
2021-06-01 |
2023-04-01 |
美商邊際分析公司 |
稠合雙環雜環化合物及其用途
|
|
TW202313051A
(zh)
|
2021-06-08 |
2023-04-01 |
美商邊際分析公司 |
使用經取代呋喃并嘧啶之病毒感染治療及方法
|
|
WO2022263829A1
(en)
|
2021-06-16 |
2022-12-22 |
Z Factor Limited |
COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
|
|
AU2022298746A1
(en)
|
2021-06-24 |
2023-11-30 |
Insilico Medicine Ip Limited |
Beta-lactam derivatives for the treatment of diseases
|
|
KR20240045220A
(ko)
|
2021-07-09 |
2024-04-05 |
다이스 알파, 인크. |
페닐 아세트아미드 기재 il-17a 조정제 및 그의 용도
|
|
IL310096A
(en)
|
2021-07-12 |
2024-03-01 |
Cytokinetics Inc |
CD38 modulators and methods of using them
|
|
MX2024002391A
(es)
|
2021-08-26 |
2024-06-03 |
Volastra Therapeutics Inc |
Inhibidores de indolina de kif18a.
|
|
CA3233328A1
(en)
|
2021-09-28 |
2023-04-06 |
Min Teng |
Lpxc inhibitors and uses thereof
|
|
WO2023070114A2
(en)
|
2021-10-22 |
2023-04-27 |
Terremoto Biosciences, Inc. |
Reversible lysine covalent modifiers of egfr and uses thereof
|
|
WO2023076866A1
(en)
|
2021-10-25 |
2023-05-04 |
Volastra Therapeutics, Inc. |
Tricyclic sulfoximine inhibitors of enpp1
|
|
EP4423084A4
(en)
*
|
2021-10-26 |
2025-12-10 |
Diamond Therapeutics Inc |
5-HT2A RECEPTOR ERGOLINE-DERIVED AGONISTS
|
|
WO2023081312A1
(en)
|
2021-11-04 |
2023-05-11 |
Vir Biotechnology, Inc. |
Small molecule inducers of autophagy
|
|
KR20240117556A
(ko)
|
2021-11-12 |
2024-08-01 |
인실리코 메디신 아이피 리미티드 |
유비퀴틴 특이적 프로테아제 1(usp1)의 소분자 억제제 및 이의 용도
|
|
WO2023086638A1
(en)
|
2021-11-15 |
2023-05-19 |
Vir Biotechnology, Inc. |
Enpp1 modulators and uses thereof
|
|
WO2023091606A1
(en)
|
2021-11-17 |
2023-05-25 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
WO2023114733A1
(en)
|
2021-12-13 |
2023-06-22 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2023114428A1
(en)
|
2021-12-16 |
2023-06-22 |
Vir Biotechnology, Inc. |
Heterocycle derivatives for the treatment of disease
|
|
WO2023114809A1
(en)
|
2021-12-16 |
2023-06-22 |
Kinnate Biopharma Inc. |
Inhibitors of met kinase
|
|
TW202342055A
(zh)
|
2022-02-03 |
2023-11-01 |
美商奇奈特生物製藥公司 |
Raf激酶抑制劑
|
|
IL314812A
(en)
|
2022-02-09 |
2024-10-01 |
Quanta Therapeutics Inc |
Kras modulators and uses thereof
|
|
CN119072465A
(zh)
|
2022-02-25 |
2024-12-03 |
戴斯阿尔法公司 |
基于二环丙基的il-17a调节剂及其用途
|
|
IL315015A
(en)
|
2022-03-01 |
2024-10-01 |
Insilico Medicine Ip Ltd |
Diacylglycerol kinase (DGK) alpha inhibitors and their uses
|
|
WO2023168291A1
(en)
|
2022-03-02 |
2023-09-07 |
Terremoto Biosciences, Inc. |
Covalent modifiers of akt1 and uses thereof
|
|
TW202342018A
(zh)
|
2022-03-04 |
2023-11-01 |
美商奇奈特生物製藥公司 |
Mek激酶抑制劑
|
|
IL315546A
(en)
|
2022-03-16 |
2024-11-01 |
Empirico Inc |
GALNAC compositions to improve siRNA bioavailability
|
|
WO2023198873A1
(en)
*
|
2022-04-14 |
2023-10-19 |
Immunic Ag |
Deuterated rorgamma/rorgammat inverse agonists
|
|
AU2023261964A1
(en)
|
2022-04-28 |
2024-11-07 |
Volastra Therapeutics, Inc. |
Compounds for inhibiting kif18a
|
|
US20250296916A1
(en)
|
2022-05-04 |
2025-09-25 |
Cytokinetics, Inc. |
Bicyclic piperazinones and therapeutic uses thereof
|
|
CN119562944A
(zh)
|
2022-05-13 |
2025-03-04 |
戴斯分子Sv有限公司 |
α4β7整合素调节剂及其用途
|
|
WO2023225001A1
(en)
|
2022-05-16 |
2023-11-23 |
Vir Biotechnology, Inc. |
Naphthyridine based enpp1 modulators and uses thereof
|
|
CN119403803A
(zh)
|
2022-05-17 |
2025-02-07 |
858治疗公司 |
Parg抑制剂
|
|
US12414948B2
(en)
|
2022-05-18 |
2025-09-16 |
Intra-Cellular Therapies, Inc. |
Methods
|
|
WO2023225664A1
(en)
|
2022-05-19 |
2023-11-23 |
Dice Alpha, Inc. |
Lactam substituted imidazopyridazine il-17a modulators and uses thereof
|
|
IL317601A
(en)
|
2022-05-25 |
2025-02-01 |
Quanta Therapeutics Inc |
Pyrimidine-based modulators and their uses
|
|
WO2023235880A1
(en)
|
2022-06-02 |
2023-12-07 |
Aeovian Pharmaceuticals, Inc. |
Cd38 modulators and uses thereof
|
|
TW202412816A
(zh)
|
2022-06-10 |
2024-04-01 |
美商弗沃德醫療公司 |
ＴＮＦ—α活性調節劑
|
|
WO2023245137A1
(en)
|
2022-06-16 |
2023-12-21 |
Cytokinetics, Incorporated |
Slow skeletal troponin activators
|
|
CN120051470A
(zh)
|
2022-07-18 |
2025-05-27 |
依安彼克医疗有限公司 |
氮杂喹唑啉化合物及使用方法
|
|
CN119894880A
(zh)
|
2022-07-18 |
2025-04-25 |
依安彼克医疗有限公司 |
喹唑啉化合物及使用方法
|
|
CA3262227A1
(en)
|
2022-07-22 |
2024-01-25 |
858 Therapeutics, Inc. |
3-(6-PYRIDIN-3-YL)-2-[4-(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)PIPERIDIN-1-YL]BENZONITRILE DERIVATIVES AND SIMILAR COMPOUNDS USED AS QPCTL AND QPCT INHIBITORS FOR CANCER TREATMENT
|
|
WO2024030825A1
(en)
|
2022-08-01 |
2024-02-08 |
Neupharma, Inc |
Crystalline salts of crystalline salts of (3s,5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl-17-(2- oxo-2h-pyran-5-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-3-yl piperazine-1-carboxylate
|
|
EP4573080A1
(en)
|
2022-08-18 |
2025-06-25 |
Cytokinetics, Inc. |
Indane and coumaran derivatives as fast skeletal muscle myosin inhibitors
|
|
WO2024064701A2
(en)
|
2022-09-20 |
2024-03-28 |
Biointervene, Inc. |
Adenosine analogs for the treatment of disease
|
|
IL319572A
(en)
|
2022-09-26 |
2025-05-01 |
Alterome Therapeutics Inc |
AKT1 modulators
|
|
WO2024073426A1
(en)
|
2022-09-26 |
2024-04-04 |
Edgewise Therapeutics, Inc. |
1,4-dihydroquinazolinone compounds and uses thereof
|
|
WO2024105159A1
(en)
|
2022-11-16 |
2024-05-23 |
University Of Zurich |
Ligands of the m6a-rna readers
|
|
EP4622981A1
(en)
|
2022-11-23 |
2025-10-01 |
Forward Therapeutics, Inc. |
Modulators of tnf-alpha activity
|
|
EP4638433A1
(en)
|
2022-12-22 |
2025-10-29 |
Cytokinetics, Inc. |
Nampt modulators
|
|
WO2024163365A1
(en)
|
2023-01-30 |
2024-08-08 |
Dice Alpha, Inc. |
Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof
|
|
CN120659787A
(zh)
|
2023-02-10 |
2025-09-16 |
维基分析有限公司 |
取代的吡唑并嘧啶及其用途
|
|
EP4665454A1
(en)
|
2023-02-13 |
2025-12-24 |
Dice Alpha, Inc. |
Imidazotriazine il-17a modulators and uses thereof
|
|
TW202438053A
(zh)
|
2023-02-23 |
2024-10-01 |
美商佛拉斯托醫療公司 |
Ｋｉｆ１８ａ吲哚啉抑制劑之固體調配物及多晶形式
|
|
EP4669432A1
(en)
|
2023-02-24 |
2025-12-31 |
Terremoto Biosciences, Inc. |
Covalent modifiers of AKT1 and their uses
|
|
PE20252443A1
(es)
|
2023-02-28 |
2025-10-20 |
Vividion Therapeutics Inc |
Derivados de 1-(([1,1'-bifenil]-2-il)sulfonil)-4-fluoro-n-(3-(metilsulfonil)alil)piperidin-4- carboxamida como moduladores de ras-pi3k para el tratamiento de, v.g., cancer
|
|
WO2024182447A1
(en)
|
2023-02-28 |
2024-09-06 |
Vividion Therapeutics, Inc. |
Compounds and methods for modulating ras-pi3k
|
|
AR132042A1
(es)
|
2023-03-02 |
2025-05-21 |
Vividion Therapeutics Inc |
Compuestos y métodos para modular stat3
|
|
EP4680609A1
(en)
|
2023-03-15 |
2026-01-21 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2024206345A1
(en)
|
2023-03-27 |
2024-10-03 |
Edgewise Therapeutics, Inc. |
Quinazoline dione compounds and uses thereof
|
|
WO2024206339A1
(en)
|
2023-03-27 |
2024-10-03 |
Edgewise Therapeutics, Inc. |
Quinolinone amide compounds and uses thereof
|
|
WO2024206347A1
(en)
|
2023-03-27 |
2024-10-03 |
Edgewise Therapeutics, Inc. |
Fused thiadiazine dioxide compounds and uses thereof
|
|
CN121311485A
(zh)
|
2023-04-11 |
2026-01-09 |
戴斯阿尔法公司 |
取代的6-咪唑并哒嗪il-17a调节剂及其用途
|
|
WO2024216094A1
(en)
|
2023-04-14 |
2024-10-17 |
Soley Therapeutics, Inc. |
Substituted phenyl-piperazinyl based modulators for the treatment of disease
|
|
TW202446377A
(zh)
|
2023-04-18 |
2024-12-01 |
美商克力歐普股份有限公司 |
Nk3調節劑及其用途
|
|
AU2024264337A1
(en)
|
2023-04-25 |
2025-10-23 |
Aeovian Pharmaceuticals, Inc. |
Tricyclic fused imidazole compounds as cd38 modulators and uses thereof
|
|
WO2024226890A1
(en)
|
2023-04-27 |
2024-10-31 |
Verge Analytics, Inc. |
Pyrazole 3h-imidazo(4,5-b)pyridine compounds and uses thereof
|
|
WO2024223953A1
(en)
|
2023-04-28 |
2024-10-31 |
Quantoom Biosciences S.A. |
Calixarene compounds, their synthesis and use in pharmaceutical compositions
|
|
WO2024229253A1
(en)
|
2023-05-04 |
2024-11-07 |
Verge Analytics, Inc. |
Methods and treatment of viral infection caused by sars-cov-2 with fused bicyclic heterocyclic compounds and uses thereof
|
|
WO2024236528A1
(en)
|
2023-05-18 |
2024-11-21 |
Insilico Medicine Ip Limited |
Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof
|
|
WO2024243085A2
(en)
|
2023-05-19 |
2024-11-28 |
Solve Therapeutics, Inc. |
Conjugates and uses thereof
|
|
WO2024259169A1
(en)
|
2023-06-13 |
2024-12-19 |
Quanta Therapeutics, Inc. |
Pyrimidine based modulators and uses thereof
|
|
WO2024259146A1
(en)
|
2023-06-14 |
2024-12-19 |
Volastra Therapeutics, Inc. |
Method of treating cancer with indoline inhibitors of kif18a
|
|
WO2024263753A1
(en)
|
2023-06-21 |
2024-12-26 |
Vir Biotechnology, Inc. |
Sulfoximine based stt3a/b modulators for the treatment of disease
|
|
WO2025007055A1
(en)
|
2023-06-29 |
2025-01-02 |
Volastra Therapeutics, Inc. |
Aryl indol-3-yl ketone and aryl indazol-3-yl ketone inhibitors of kif18a
|
|
WO2025005748A1
(ko)
|
2023-06-29 |
2025-01-02 |
(주)아이젠사이언스 |
신규 셀레노펜 유도체
|
|
WO2025014830A1
(en)
|
2023-07-07 |
2025-01-16 |
Solve Therapeutics, Inc. |
Conjugates of drug units and targeting units and precursor compounds thereof
|
|
US12157722B1
(en)
|
2023-08-03 |
2024-12-03 |
Gilgamesh Pharmaceuticals, Inc. |
Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine
|
|
WO2025034613A1
(en)
|
2023-08-04 |
2025-02-13 |
Terremoto Biosciences, Inc. |
3h-imidazo[4,5-b]pyridine compounds as non-covalent modifiers of akt1 and uses thereof
|
|
WO2025034919A1
(en)
|
2023-08-08 |
2025-02-13 |
Quanta Therapeutics, Inc. |
Combination therapies with kras modulators
|
|
WO2025034883A1
(en)
|
2023-08-08 |
2025-02-13 |
Quanta Therapeutics, Inc. |
Combination therapies with kras modulators
|
|
WO2025032214A1
(en)
|
2023-08-09 |
2025-02-13 |
Pierre Fabre Medicament |
Indazole compounds and azaindazole compounds as inhibitors of raf kinases
|
|
WO2025037206A1
(en)
*
|
2023-08-11 |
2025-02-20 |
Pfizer Inc. |
Deuterated antiviral compounds
|
|
WO2025049402A1
(en)
|
2023-08-28 |
2025-03-06 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2025049641A1
(en)
|
2023-08-29 |
2025-03-06 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2025049619A1
(en)
|
2023-08-29 |
2025-03-06 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2025058977A1
(en)
|
2023-09-11 |
2025-03-20 |
Vir Biotechnology, Inc. |
Modulators of coronavirus 3c-like protease and uses thereof
|
|
TW202528314A
(zh)
|
2023-09-20 |
2025-07-16 |
美商亞特羅姆醫療公司 |
Ｋｒａｓ調節劑
|
|
WO2025072451A1
(en)
|
2023-09-27 |
2025-04-03 |
Vividion Therapeutics, Inc. |
Ras-pi3k inhibitors for the treatment of cancer and immunological diseases
|
|
WO2025081045A1
(en)
|
2023-10-13 |
2025-04-17 |
Terremoto Biosciences, Inc. |
Cysteine covalent modifiers of akt1 and uses thereof
|
|
WO2025081012A1
(en)
|
2023-10-13 |
2025-04-17 |
Mbx Biosciences, Inc. |
Pharmaceutical compositions and uses thereof
|
|
WO2025090640A1
(en)
|
2023-10-23 |
2025-05-01 |
Volastra Therapeutics, Inc. |
Solid formulations and polymorphic forms of indoline inhibitors of kif18a
|
|
TW202527929A
(zh)
|
2023-10-24 |
2025-07-16 |
美商特瑞莫托生物科學股份有限公司 |
Ｃｄｋ２之可逆性離胺酸共價修飾劑及其用途
|
|
WO2025096957A1
(en)
|
2023-11-03 |
2025-05-08 |
Vividion Therapeutics, Inc. |
Ras-pi3k inhibitors and uses thereof
|
|
WO2025106410A1
(en)
|
2023-11-15 |
2025-05-22 |
Dice Molecules Sv, Inc. |
Alpha 4 beta 7 integrin modulators and uses thereof
|
|
WO2025106843A1
(en)
|
2023-11-15 |
2025-05-22 |
Dice Molecules Sv, Inc. |
Alpha 4 beta 7 integrin modulators and uses thereof
|
|
WO2025106905A1
(en)
|
2023-11-17 |
2025-05-22 |
Quanta Therapeutics, Inc. |
Combination therapies with a kras modulator and an immunomodulator inhibitor
|
|
WO2025106901A1
(en)
|
2023-11-17 |
2025-05-22 |
Quanta Therapeutics, Inc. |
Combination cancer therapies with a kras modulator and an rtk-mapk pathway inhibitor
|
|
WO2025133989A1
(en)
|
2023-12-20 |
2025-06-26 |
Alt-Bio Pte. Ltd. |
Smyd modulators and uses thereof
|
|
WO2025155740A1
(en)
|
2024-01-17 |
2025-07-24 |
Iambic Therapeutics, Inc. |
Combinations comprising aza-quinazoline compounds for use in the treatment of cancer
|
|
WO2025155742A1
(en)
|
2024-01-17 |
2025-07-24 |
Iambic Therapeutics, Inc. |
Methods of use for quinazoline compounds
|
|
WO2025175141A1
(en)
|
2024-02-16 |
2025-08-21 |
Cytokinetics, Incorporated |
Fast skeletal muscle myosin inhibitors
|
|
WO2025207679A1
(en)
|
2024-03-26 |
2025-10-02 |
Edgewise Therapeutics, Inc. |
Quinazoline dione compounds and uses thereof
|
|
WO2025207622A1
(en)
|
2024-03-26 |
2025-10-02 |
Edgewise Therapeutics, Inc. |
Quinolinone, benzoxazinone, and quinoline compounds and uses thereof
|
|
WO2025207677A1
(en)
|
2024-03-26 |
2025-10-02 |
Edgewise Therapeutics, Inc. |
Quinazolinone compounds and uses thereof
|
|
WO2025207665A1
(en)
|
2024-03-26 |
2025-10-02 |
Edgewise Therapeutics, Inc. |
Quinolinone compounds and uses thereof
|
|
WO2025212627A1
(en)
|
2024-04-03 |
2025-10-09 |
Forward Therapeutics, Inc. |
Modulators of tnf-alpha activity
|
|
WO2025217336A1
(en)
|
2024-04-10 |
2025-10-16 |
Terremoto Biosciences, Inc. |
Cysteine covalent modifiers of akt1 and uses thereof
|
|
WO2025217330A1
(en)
|
2024-04-10 |
2025-10-16 |
Terremoto Biosciences, Inc. |
Cysteine covalent modifiers of akt1 and uses thereof
|
|
WO2025226868A1
(en)
|
2024-04-23 |
2025-10-30 |
Hexagon Bio, Inc. |
Antibody drug conjugates and uses thereof
|
|
WO2025227060A1
(en)
|
2024-04-26 |
2025-10-30 |
Insilico Medicine Ip Limited |
Heterocyclic inhibitors of ubiquitin specific protease 1 (usp1) in combination with additional agents for use in the treatment of cancer
|
|
WO2025231037A1
(en)
|
2024-04-30 |
2025-11-06 |
Solve Therapeutics, Inc. |
Conjugates of anti-ptk7 antibodies
|
|
WO2025255014A1
(en)
|
2024-06-03 |
2025-12-11 |
Soley Therapeutics, Inc. |
Substituted heterocyclic modulators for the treatment of disease
|
|
WO2025255134A1
(en)
|
2024-06-04 |
2025-12-11 |
Soley Therapeutics, Inc. |
Piperazinone based modulators for the treatment of disease
|
|
WO2026011158A1
(en)
|
2024-07-05 |
2026-01-08 |
Solve Therapeutics, Inc. |
Conjugate of a drug and a 5t4 ligand and uses thereof
|